Sublingual immunotherapy in preschool children: An update

Expert Review of Clinical Immunology

Volumn 9, Issue 4, 2013, Pages 385-390

  Vitaliti, Giovanna ^a   Pavone, Piero ^a   Guglielmo, Francesco ^a   Falsaperla, Raffaele ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

efficacy; literature review; preschool children; safety; sublingual immunotherapy

Indexed keywords

PLACEBO;

ABDOMINAL PAIN; ALLERGIC RHINITIS; ALTERNARIA; ALTERNARIOSIS; ASIA; ASTHMA; AUSTRALIA; DRUG EFFICACY; DRUG SAFETY; EUROPE; HOUSE DUST ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; META ANALYSIS (TOPIC); MUCOSAL IMMUNITY; PARIETARIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC);

ADMINISTRATION, SUBLINGUAL; ASIA; AUSTRALIA; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY HYPERSENSITIVITY;

EID: 84875921314     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.13.7     Document Type: Review

References (55)

1. Potter PC. Update on sublingual immunotherapy. Ann. Allergy Asthma Immunol. 96(2 Suppl. 1), S22-S25 (2006
2. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J. Allergy Clin. Immunol. 111(3), 437-448; quiz 449 (2003
3. Kowalski ML. Systemic and specific treatment for a global disease: Allergen immunotherapy revisited. Allergy 61(7), 791-795 (2006
4. Enrique E, Pineda F, Malek T et al. Sublingual immunotherapy for hazelnut food allergy: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol. 116(5), 1073-1079 (2005
5. Pajno GB, Caminiti L, Vita D et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo- controlled study. J. Allergy Clin. Immunol. 120(1), 164-170 (2007
6. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children-a 14-year study. Pediatrics 42(5), 793-802 (1968
7. Aas K. Hyposensitization in house dust allergy asthma. A double-blind controlled study with evaluation of the effect on bronchial sensitivity to house dust. Acta Paediatr. Scand. 60(3), 264-268 (1971
8. Bousquet J, Lockey R, Malling HJ. World Health Organization Position Paper. Allergen immunotherapy: Therapeutical vaccines for allergic diseases. Allergy 44(Suppl. 53), 1-43 (1998
9. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J. Allergy Clin. Immunol. 85(2), 473-479 (1990
10. Ostergaard PA, Kaad PH, Kristensen T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy 41(8), 588-593 (1986
11. Rienzo VD, Minelli M, Musarra A et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin. Exp. Allergy 35(5), 560-564 (2005
12. Fiocchi A, Pajno G, La Grutta S et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann. Allergy Asthma Immunol. 95(3), 254-258 (2005
13. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E; EAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy. Allergy 61(Suppl. 82), 1-20 (2006
14. Bronnert M, Mancini J, Birnbaum J et al. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: Relevant markers for house dust mite allergy. Clin. Exp. Allergy 42(9), 1406-1415) (2012
15. Melioli G, Bonifazi F, Bonini S et al.; Italian Board for ISAC (IBI). The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin. Biochem. 44(12), 1005-1011 (2011
16. Allam JP, Novak N, Fuchs C et al. Characterization of dendritic cells from human oral mucosa: A new Langerhans' cell type with high constitutive FcepsilonRI expression. J. Allergy Clin. Immunol. 112(1), 141-148 (2003
17. Hasséus B, Jontell M, Bergenholtz G, Dahlgren UI. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin. Exp. Immunol. 136(3), 483-489 (2004
18. Cuburu N, Kweon MN, Song JH et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25(51), 8598-8610 (2007
19. Holt PG, Vines J, Britten D. Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses. Clin. Allergy 18(3), 229-234 (1988
20. Vitaliti G, Leonardi S, Miraglia Del Giudice M et al. Mucosal immunity and sublingual immunotherapy in respiratory disorders. J. Biol. Regul. Homeost. Agents 26(Suppl. 1), S85-S93 (2012
21. Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F. Dose dependence of immunological response to sublingual immunotherapy. Allergy 60(7), 952-956 (2005
22. Brimnes J, Kildsgaard J, Jacobi H, Lund K. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin. Exp. Allergy 37(4), 488-497 (2007
23. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61(2), 151-165 (2006
24. Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergenspecific immunotherapy. Nat. Rev. Immunol. 6(10), 761-771 (2006
25. Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 61(Suppl. 81), 11-14 (2006
26. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120(3), 707-713 (2007
27. Savolainen J, Nieminen K, Laaksonen K et al. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy 62(8), 949-953 (2007
28. Kildsgaard J, Brimnes J, Jacobi H, Lund K. Sublingual immunotherapy in sensitized mice. Ann. Allergy Asthma Immunol. 98(4), 366-372 (2007
29. Yoshitomi T, Nakagami Y, Hirahara K, Taniguchi Y, Sakaguchi M, Yamashita M. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice. J. Pept. Sci. 13(8), 499-503 (2007
30. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: Systematic review and meta-analysis. Allergy 60(1), 4-12 (2005
31. Penagos M, Compalati E, Tarantini F et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: A meta-analysis of randomized, placebocontrolled, double-blind trials. Ann. Allergy Asthma Immunol. 97(2), 141-148 (2006
32. Businco L, Zannino L, Cantani A, Corrias A, Fiocchi A, La Rosa M. Systemic reactions to specific immunotherapy in children with respiratory allergy: A prospective study. Pediatr. Allergy Immunol. 6(1), 44-47 (1995
33. Cantani A, Arcese G, Lucenti P, Gagliesi D, Bartolucci M. A three-year prospective study of specific immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma. J. Investig. Allergol. Clin. Immunol. 7(2), 90-97 (1997
34. Akçakaya N, Hassanzadeh A, Camcioglu Y, Cokugras H. Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children. Ann. Allergy Asthma Immunol. 85(4), 317-321 (2000
35. Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW. Efficacy and safety of sublingual immunotherapy. Ann. Allergy Asthma Immunol. 93(1), 3-12; quiz 12 (2004
36. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 54(10), 1110-1113 (1999
37. Di Rienzo V, Marcucci F, Puccinelli P et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: A 10-year prospective study. Clin. Exp. Allergy 33(2), 206-210 (2003
38. Rolinck-Werninghaus C, Wolf H, Liebke C et al. A prospective, randomized, doubleblind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 59(12), 1285-1293 (2004
39. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 66(6), 740-752 (2011
40. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis-based comparison. J. Allergy Clin. Immunol. 130(5), 1097-1107.e2 (2012
41. Malling HJ, Weeke B. Immunotherapy: Position paper. Allergy 48(Suppl. 14), 9-35 (1993
42. Ownby DR, Adinoff AD. The appropriate use of skin testing and allergen immunotherapy in young children. J. Allergy Clin. Immunol. 94(4), 662-665 (1994
43. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108(Suppl. 5), S147-S334 (2001
44. Li JT, Lockey RF, Bernstein IL et al. Allergen immunotherapy: A practice parameter. Ann. Allergy Asthma Immunol. 90, 1-40 (2003
45. DuBuske LM. Appropriate and inappropriate use of immunotherapy. Ann. Allergy Asthma Immunol. 87(1 Suppl. 1), 56-67 (2001
46. Agostinis F, Tellarini L, Canonica GW, Falagiani P, Passalacqua G. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy 60(1), 133 (2005
47. Tonnel AB, Scherpereel A, Douay B et al. Allergic rhinitis due to house dust mites: Evaluation of the efficacy of specific sublingual immunotherapy. Allergy 59(5), 491-497 (2004
48. Moreno C, Cuesta-Herranz J, Fernández Távora L, Alvarez-Cuesta E; Immunotherapy Committee, Sociedad Española de Alergología e Inmunología Clínica. Immunotherapy safety: A prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin. Exp. Allergy 34(4), 527-531 (2004
49. Pajno GB, Peroni DG, Vita D, Pietrobelli A, Parmiani S, Boner AL. Safety of sublingual immunotherapy in children with asthma. Paediatr. Drugs 5(11), 777-781 (2003
50. André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int. Arch. Allergy Immunol. 121(3), 229-234 (2000
51. Mosbech H, Dreborg S, Madsen F et al. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study. Allergy 42(6), 451-455 (1987
52. Passalacqua G, Villa G, Altrinetti V et al Sublingual swallow or spit? Allergy 56(6), 578 (2001
53. Passalacqua G. Specific immunotherapy: Beyond the clinical scores. Ann. Allergy Asthma Immunol. 107(5), 401-406 (2011
54. Canonica GW. WAO Position Paper on sublingual immunotherapy. Allergy 66(Suppl. 82), 3-33 (2009
55. Pajno GB, Caminiti L, Crisafulli G et al. Adherence to sublingual immunotherapy in preschool children. Pediatr. Allergy Immunol. 23(7), 688-689 (2012